Clin Mol Hepatol.
2026 Jul;32(3):e422-e423. 10.3350/cmh.2026.0075.
Correspondence to letter to the editor on “Hypothyroidism and the risk of liver-related events in patients with metabolic dysfunction-associated steatotic liver disease”
- Affiliations
-
- 1Department of Medicine and Therapeutics, The Chinese University of Hong Kong, China
- 2Medical Data Analytics Center, The Chinese University of Hong Kong, China
- 3State Key Laboratory of Digestive Disease, Institute of Digestive Disease, The Chinese University of Hong Kong, China
- 4Li Ka Shing Institute of Health Sciences, The Chinese University of Hong Kong, Hong Kong, China
- KMID: 2583129
- DOI: http://doi.org/10.3350/cmh.2026.0075
Keyword
- Full Text Links
-
- Actions
-
Cited
- CITED
-
- Close
- Share
-
- Similar articles
-
- A call for more efforts to incorporate liver in the metabolic health framework: Letter to the editor on “Hypothyroidism and the risk of liver-related events in patients with metabolic dysfunction-associated steatotic liver disease”
- Reply to correspondence on “Hypothyroidism and the risk of liver-related events in patients with metabolic dysfunction-associated steatotic liver disease”
- Correspondence to letter to the editor on “Risk stratification by noninvasive tests in patients with metabolic dysfunction-associated steatotic liver disease”
- Correspondence to letter to the editor on “Histological severity and hepatic outcomes in patients with metabolic dysfunction-associated steatotic liver disease and discrepant FIB-4 and liver stiffness measurement”
- Correspondence to letter to the editor on “Glucagon-like peptide 1 receptor agonist and reduced liver and non-liver complications in adults with type 2 diabetes and metabolic dysfunction-associated steatotic liver disease: a target trial emulation study”
